MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$55,341K
EPS
-$0.37
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
0
0
0
53,811
Research and development
37,199
33,534
32,101
30,815
General and administrative
22,586
15,235
9,763
8,924
Total operating expenses
59,785
48,769
41,864
39,739
Loss from operations
-59,785
-48,769
-41,864
14,072
Interest income
3,723
2,177
1,680
1,097
Other income, net
722
1,079
1,380
705
Total other income, net
4,445
3,256
3,060
1,802
Loss before income taxes
-55,340
-45,513
-38,804
15,874
Provision for income taxes
1
1
-55
-10
Net loss
-55,341
-45,514
-38,749
15,884
Unrealized (gain) loss on marketable securities
-
-
130
-
Comprehensive gain
-
-
-38,619
-
Basic EPS
-0.37
-0.32
-0.291
0.14
Diluted EPS
-0.37
-0.32
-0.306
0.13
Basic Average Shares
149,875,939
143,576,292
132,856,311
110,966,345
Diluted Average Shares
149,875,939
143,576,292
126,040,582
117,782,074
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$55,341K
(-42.44%↓ Y/Y)
Interest income
$3,723K
(200.48%↑ Y/Y)
Other income, net
$722K
(-20.66%↓ Y/Y)
Loss before income
taxes
-$55,340K
(-42.56%↓ Y/Y)
Provision for income taxes
$1K
(-97.14%↓ Y/Y)
Total other income,
net
$4,445K
(106.84%↑ Y/Y)
Loss from operations
-$59,785K
(-45.93%↓ Y/Y)
Total operating
expenses
$59,785K
(35.42%↑ Y/Y)
Research and development
$37,199K
(13.39%↑ Y/Y)
General and
administrative
$22,586K
(99.15%↑ Y/Y)
Buy us a coffee
TNGX_BIG
Tango Therapeutics, Inc. (TNGX)
TNGX_BIG
Tango Therapeutics, Inc. (TNGX)